Endotoxin and Bronchial Inflammation in Asthma

NCT00005550 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2014-08-11

No results posted yet for this study

Summary

To evaluate airway inflammation in persons with asthma exposed to endotoxin, a common occupational air contaminant. Subjects are subsequently challenged with allergen.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • David Peden · University of North Carolina

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-31
Primary Completion
2006-12-31
Completion
2006-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005550 on ClinicalTrials.gov